Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study.

IF 12.5 2区 医学 Q1 SURGERY
Qiong Ma, Chun-Xia Huang, Jia-Wei He, Xiao Zeng, Yu-Li Qu, Hong-Xia Xiang, Yang Zhong, Mao Lei, Ru-Yi Zheng, Jun-Jie Xiao, Yu-Ling Jiang, Shi-Yan Tan, Ping Xiao, Xiang Zhuang, Li-Ting You, Xi Fu, Yi-Feng Ren, Chuan Zheng, Feng-Ming You
{"title":"Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study.","authors":"Qiong Ma, Chun-Xia Huang, Jia-Wei He, Xiao Zeng, Yu-Li Qu, Hong-Xia Xiang, Yang Zhong, Mao Lei, Ru-Yi Zheng, Jun-Jie Xiao, Yu-Ling Jiang, Shi-Yan Tan, Ping Xiao, Xiang Zhuang, Li-Ting You, Xi Fu, Yi-Feng Ren, Chuan Zheng, Feng-Ming You","doi":"10.1097/JS9.0000000000002152","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Determining the benign or malignant status of indeterminate pulmonary nodules (IPN) with intermediate malignancy risk is a significant clinical challenge. Oral microbiota-lung cancer (LC) interactions have qualified oral microbiota as a promising non-invasive predictive biomarker in IPN.</p><p><strong>Materials and methods: </strong>Prospectively collected saliva, throat swabs, and tongue coating samples from 1040 IPN patients and 70 healthy controls across three hospitals. Following up, the IPNs were diagnosed as benign (BPN) or malignant pulmonary nodules (MPN). Through 16S rRNA sequencing, bioinformatics analysis, fluorescence in situ hybridization (FISH), and seven machine learning algorithms (support vector machine, logistic regression, naïve Bayes, multi-layer perceptron, random forest, gradient-boosting decision tree, and LightGBM), we revealed the oral microbiota characteristics at different stages of HC-BPN-MPN, identified the sample types with the highest predictive potential, constructed and evaluated the optimal MPN prediction model for predictive efficacy, and determined microbial biomarkers. Additionally, based on the SHAP algorithm interpretation of the ML model's output, we have developed a visualized IPN risk prediction system on the web.</p><p><strong>Results: </strong>Saliva, tongue coating, and throat swab microbiotas exhibit site-specific characteristics, with saliva microbiota being the optimal sample type for disease prediction. The saliva-LightGBM model demonstrated the best predictive performance (AUC = 0.887, 95%CI: 0.865-0.918), and identified Actinomyces, Rothia, Streptococcus, Prevotella, Porphyromonas , and Veillonella as biomarkers for predicting MPN. FISH was used to confirm the presence of a microbiota within tumors, and external data from a LC cohort, along with three non-IPN disease cohorts, were employed to validate the specificity of the microbial biomarkers. Notably, coabundance analysis of the ecological network revealed that microbial biomarkers exhibit richer interspecies connections within the MPN, which may contribute to the pathogenesis of MPN.</p><p><strong>Conclusion: </strong>This study presents a new predictive strategy for the clinic to determine MPNs from BPNs, which aids in the surgical decision-making for IPN.</p>","PeriodicalId":14401,"journal":{"name":"International journal of surgery","volume":" ","pages":"2055-2071"},"PeriodicalIF":12.5000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JS9.0000000000002152","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Determining the benign or malignant status of indeterminate pulmonary nodules (IPN) with intermediate malignancy risk is a significant clinical challenge. Oral microbiota-lung cancer (LC) interactions have qualified oral microbiota as a promising non-invasive predictive biomarker in IPN.

Materials and methods: Prospectively collected saliva, throat swabs, and tongue coating samples from 1040 IPN patients and 70 healthy controls across three hospitals. Following up, the IPNs were diagnosed as benign (BPN) or malignant pulmonary nodules (MPN). Through 16S rRNA sequencing, bioinformatics analysis, fluorescence in situ hybridization (FISH), and seven machine learning algorithms (support vector machine, logistic regression, naïve Bayes, multi-layer perceptron, random forest, gradient-boosting decision tree, and LightGBM), we revealed the oral microbiota characteristics at different stages of HC-BPN-MPN, identified the sample types with the highest predictive potential, constructed and evaluated the optimal MPN prediction model for predictive efficacy, and determined microbial biomarkers. Additionally, based on the SHAP algorithm interpretation of the ML model's output, we have developed a visualized IPN risk prediction system on the web.

Results: Saliva, tongue coating, and throat swab microbiotas exhibit site-specific characteristics, with saliva microbiota being the optimal sample type for disease prediction. The saliva-LightGBM model demonstrated the best predictive performance (AUC = 0.887, 95%CI: 0.865-0.918), and identified Actinomyces, Rothia, Streptococcus, Prevotella, Porphyromonas , and Veillonella as biomarkers for predicting MPN. FISH was used to confirm the presence of a microbiota within tumors, and external data from a LC cohort, along with three non-IPN disease cohorts, were employed to validate the specificity of the microbial biomarkers. Notably, coabundance analysis of the ecological network revealed that microbial biomarkers exhibit richer interspecies connections within the MPN, which may contribute to the pathogenesis of MPN.

Conclusion: This study presents a new predictive strategy for the clinic to determine MPNs from BPNs, which aids in the surgical decision-making for IPN.

口腔微生物群作为预测不确定肺结节恶性风险的生物标志物:一项前瞻性多中心研究。
背景:确定具有中等恶性风险的不确定肺结节(IPN)的良恶性状态是一项重大的临床挑战。口腔微生物与肺癌的相互作用使口腔微生物群成为一种有前途的非侵入性预测IPN的生物标志物。材料和方法:前瞻性收集来自三家医院的1040名IPN患者和70名健康对照者的唾液、咽拭子和舌苔样本。随访,诊断为良性(BPN)或恶性肺结节(MPN)。通过16S rRNA测序、生物信息学分析、荧光原位杂交(FISH)和7种机器学习算法(支持向量机、逻辑回归、naïve贝叶斯、多层感知器、随机森林、梯度增强决策树和LightGBM),揭示了HC-BPN-MPN不同阶段的口腔微生物群特征,确定了预测潜力最大的样品类型。构建并评估最佳MPN预测模型的预测效果,并确定微生物生物标志物。此外,基于对ML模型输出的SHAP算法解释,我们在网络上开发了一个可视化的IPN风险预测系统。结果:唾液、舌苔和咽拭子微生物群表现出部位特异性特征,唾液微生物群是疾病预测的最佳样本类型。唾液- lightgbm模型预测效果最佳(AUC = 0.887, 95%CI: 0.865-0.918),并鉴定出放线菌、罗氏菌、链球菌、普雷沃菌、卟啉单胞菌和细孔菌作为预测MPN的生物标志物。FISH用于确认肿瘤内微生物群的存在,并使用来自肺癌队列以及三个非ipn疾病队列的外部数据来验证微生物生物标志物的特异性。值得注意的是,生态网络的共丰度分析显示,微生物生物标志物在MPN中表现出更丰富的种间联系,这可能有助于MPN的发病机制。结论:本研究提出了一种新的预测策略,用于临床从bpn中确定mpn,有助于IPN的手术决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
17.70
自引率
3.30%
发文量
0
审稿时长
6-12 weeks
期刊介绍: The International Journal of Surgery (IJS) has a broad scope, encompassing all surgical specialties. Its primary objective is to facilitate the exchange of crucial ideas and lines of thought between and across these specialties.By doing so, the journal aims to counter the growing trend of increasing sub-specialization, which can result in "tunnel-vision" and the isolation of significant surgical advancements within specific specialties.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信